|1.||Burow, Matthew E: 5 articles (06/2015 - 01/2006)|
|2.||Hartman, Glen L: 4 articles (01/2014 - 07/2004)|
|3.||Zernova, Olga V: 4 articles (01/2014 - 07/2004)|
|4.||Lozovaya, Vera V: 4 articles (01/2014 - 07/2004)|
|5.||Widholm, Jack M: 4 articles (01/2014 - 07/2004)|
|6.||Elliott, Steven: 3 articles (06/2015 - 12/2006)|
|7.||McLachlan, John A: 3 articles (06/2015 - 12/2006)|
|8.||Collins-Burow, Bridgette M: 3 articles (06/2015 - 12/2006)|
|9.||Boué, Stephen M: 3 articles (01/2015 - 12/2006)|
|10.||Lygin, Anatoliy V: 3 articles (10/2013 - 07/2004)|
10/01/2013 - "The aim of this study is to determine the effect of glyceollin treatment on EPCs during early tumor vasculogenesis. "
01/01/2010 - "Our previous publications have focused specifically on inhibition of tumor formation and growth by the glyceollin mixture, which contains three glyceollin isomers (I, II, and III). "
12/01/2006 - "Treatment with glyceollin suppressed E2-stimulated tumor growth of MCF-7 cells (-53.4%) and BG-1 cells (-73.1%) in ovariectomized athymic mice. "
01/01/2015 - "In vivo studies performed in ovariectomized, female nude mice indicated that glyceollin treated tumors stained weakly for ZEB1 and N-cadherin and strongly for E-cadherin. "
06/01/2015 - "Here we demonstrate glyceollin, an activated soy compound, has anti-estrogen effects in breast cancers. "
|2.||Body Weight (Weight, Body)
|3.||Breast Neoplasms (Breast Cancer)
06/01/2015 - "Glyceollin, a novel regulator of mTOR/p70S6 in estrogen receptor positive breast cancer."
01/01/2015 - "These effects of glyceollin I were mediated in part by inhibition of ZEB1, thus indicating therapeutic potential of glyceollin I in targeting EMT in letrozole resistant breast cancer. "
01/01/2015 - "Glyceollin I Reverses Epithelial to Mesenchymal Transition in Letrozole Resistant Breast Cancer through ZEB1."
01/01/2015 - "Letrozole-resistant breast cancer cells (LTLT-Ca) were treated with a novel phytoalexin, glyceollin I, and exhibited morphological characteristics synonymous with an epithelial phenotype and decreased proliferation. "
01/01/2006 - "The purpose of this study was to evaluate the estrogen-antagonist effects of glyceollin-enriched soy protein on biomarkers for breast cancer risk. "
10/01/2013 - "These results provide further evidence that rapid glyceollin accumulation during infection contributes to the innate soybean defense response."
10/01/2013 - "phaseolina, suppression of glyceollin synthesis was found only in stems of transgenic plants expressing the transgene driven by a constitutive promoter, which developed more severe infection. "
07/01/2004 - "The data obtained indicate that the ability of soybean roots to rapidly produce sufficient amounts of glyceollin in response to FSG infection might be important in providing partial resistance to this fungus."
09/01/1995 - "These results suggest possible reasons for the rapid induction of glyceollin synthesis immediately after infection of resistant soybean cultivars with H. "
04/01/1986 - "The results show that infection of soybean roots with zoospores of Pmg race 1 causes a race:cultivar-specific early induction of enzymes involved in glyceollin synthesis, whereas such an induction does not occur with zoospores of race 3. These findings are in agreement with the race:cultivar-specific accumulation of glyceollin in soybean roots reported previously [M. "
|5.||Ovarian Neoplasms (Ovarian Cancer)
04/01/2011 - "This review covers the biosynthesis of glyceollin and its biological activities including antiproliferative/antitumor action (toward B16 melanoma cells, LNCaP prostate cancer cells, and BG-1 ovarian cancer cells), anti-estrogenic action (through estrogen receptors α- and β-), antibacterial action (toward Erwinia carotovora, Escherichia coli, Bradyrhizobium japonicum, Sinorhizobium fredii ), antinematode activity, and antifungal activity (toward Fusarium solani, Phakospora pachyrhizi, Diaporthe phaseolorum, Macrophomina phaseolina, Sclerotina sclerotiorum, Phytophthora sojae, Cercospora sojina, Phialophora gregata, and Rhizoctonia solani). "
01/01/2010 - "Ligand-receptor modeling (docking) of glyceollin I, II, and III within the ERalpha ligand binding cavity demonstrates a unique type II antiestrogenic confirmation adopted by glyceollin I but not isomers II and III. We further compared the effects of glyceollin I to the antiestrogens, 4-hydroxytamoxifen and ICI 182,780 (fulvestrant), in MCF-7 breast cancer cells and BG-1 ovarian cancer cells on 17beta-estradiol-stimulated expression of progesterone receptor and stromal derived factor-1alpha. "
|5.||Soybean Proteins (Soy Protein)
|7.||Biological Markers (Surrogate Marker)